Skip to main content
. 2014 Feb 28;3(1):e000403. doi: 10.1161/JAHA.113.000403

Table 2.

Potential Utility and Challenges of the High‐Sensitivity Troponin Assay

Potential Utility Potential Challenges
More rapid diagnosis in ACS Nonspecific to etiology
Population screening False‐positive interpretation
Prognostic information in stable patients Biological variability
Drug development and cardiotoxicity Lack of assay standardization

ACS indicates acute coronary syndrome.